Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

8-cyclopentlyl-1,3-dipropylxanthine

EU orphan designation number: EU/3/01/030
Active ingredient: 8-cyclopentlyl-1,3-dipropylxanthine
Indication: Treatment of cystic fibrosis
Sponsor: SciClone Pharmaceuticals Italy S.r.l
Via Lisbona 11, 00198 Roma, Italia

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/03/2001 Orphan designation EMEA/OD/064/00 (2001)949 of 29/03/2001
04/08/2008 Removal of orphan designation from Community Register